Paragon Private Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$969K Sell
15,447
-503
-3% -$40.2K 0.3% 92
2025
Q4
$1.52M Buy
15,950
+185
+1% +$18.1K 0.47% 53
2025
Q3
$1.54M Buy
15,765
+3,986
+34% +$413K 0.5% 53
2025
Q2
$1.27M Buy
11,779
+1,715
+17% +$174K 0.5% 54
2025
Q1
$1.02M Buy
10,064
+1,917
+24% +$193K 0.47% 65
2024
Q4
$728K Buy
8,147
+1,529
+23% +$135K 0.34% 82
2024
Q3
$555K Buy
6,618
+1,325
+25% +$104K 0.27% 97
2024
Q2
$408K Buy
+5,293
New +$387K 0.23% 105

Other funds holding BSX

Paragon Private Wealth Management's BSX Position: Q1 2026 in Review

Paragon Private Wealth Management reduced its Boston Scientific (BSX) stake by 3.2% in Q1 2026, selling an estimated $40.2K and leaving 15,447 shares worth $969K. The position accounts for 0.3% of the portfolio, ranked #92.

Paragon Private Wealth Management first reported a position in BSX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.54M in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Paragon Private Wealth Management held 15,447 shares of Boston Scientific worth $969K as of Q1 2026.
  • Paragon Private Wealth Management sold 503 Boston Scientific shares in Q1 2026, an estimated $40.2K.
  • Boston Scientific made up 0.3% of Paragon Private Wealth Management's portfolio in Q1 2026, its #92 holding.
  • Paragon Private Wealth Management first reported a position in Boston Scientific in Q2 2024 and has held it in 8 quarters since.
  • Paragon Private Wealth Management's Boston Scientific position peaked at $1.54M in Q3 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Paragon Private Wealth Management's 13F filing for Q1 2026, filed 19 May 2026.